Audentes Therapeutics, Inc. Increase (Decrease) in Accrued Liabilities
Audentes Therapeutics, Inc. reported Increase (Decrease) in Accrued Liabilities of $1.55 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2019-11-07
- Audentes Therapeutics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2019-09-30 was $752.00K, a 73.03% decline year-over-year.
- Audentes Therapeutics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2019-06-30 was $3.44M, a 15.48% decline year-over-year.
- Audentes Therapeutics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2019-03-31 was -$2.64M.
- Audentes Therapeutics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2018-12-31 was -$2.62M.
- Audentes Therapeutics, Inc. increase (decrease) in accrued liabilities for fiscal 2018 was $2.02M.
- Audentes Therapeutics, Inc. increase (decrease) in accrued liabilities for fiscal 2017 was -$1.58M, a 132.79% decline from fiscal 2016.
- Audentes Therapeutics, Inc. increase (decrease) in accrued liabilities for fiscal 2016 was $4.82M, a 82.80% increase from fiscal 2015.
- Audentes Therapeutics, Inc. increase (decrease) in accrued liabilities for fiscal 2015 was $2.63M, a 56.51% increase from fiscal 2014.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2019-09-30 | $752.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $4.19M derived: sum of 2 quarters · filed 2019-11-07 | $1.55M 10-Q · filed 2019-11-07 | -$1.07M derived: sum of 4 quarters · filed 2019-11-07 |
| 2019-06-30 | $3.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $796.00K 10-Q · filed 2019-08-07 | -$1.82M derived: sum of 3 quarters · filed 2019-08-07 | $966.00K derived: sum of 4 quarters · filed 2019-11-07 |
| 2019-03-31 | -$2.64M 10-Q · filed 2019-05-08 | -$5.26M derived: sum of 2 quarters · filed 2019-05-08 | -$2.47M derived: sum of 3 quarters · filed 2019-11-07 | $1.60M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-12-31 | -$2.62M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $170.00K derived: sum of 2 quarters · filed 2019-11-07 | $4.24M derived: sum of 3 quarters · filed 2019-11-07 | $2.02M 10-K · filed 2019-03-01 |
| 2018-09-30 | $2.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $6.86M derived: sum of 2 quarters · filed 2019-11-07 | $4.63M 10-Q · filed 2019-11-07 | $4.60M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $4.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $1.85M 10-Q · filed 2019-08-07 | $1.81M derived: sum of 3 quarters · filed 2019-08-07 | $1.08M derived: sum of 4 quarters · filed 2019-08-07 |
| 2018-03-31 | -$2.22M 10-Q · filed 2019-05-08 | -$2.25M derived: sum of 2 quarters · filed 2019-05-08 | -$2.99M derived: sum of 3 quarters · filed 2019-05-08 | -$773.00K derived: sum of 4 quarters · filed 2019-05-08 |
| 2017-12-31 | -$32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$769.00K derived: sum of 2 quarters · filed 2019-03-01 | $1.45M derived: sum of 3 quarters · filed 2019-03-01 | -$1.58M 10-K · filed 2019-03-01 |
| 2017-09-30 | -$737.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $1.48M derived: sum of 2 quarters · filed 2018-11-07 | -$1.55M 10-Q · filed 2018-11-07 | $2.05M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $2.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$810.00K 10-Q · filed 2018-08-07 | $2.79M derived: sum of 3 quarters · filed 2019-03-01 | $2.99M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | -$3.03M 10-Q · filed 2018-05-10 | $568.00K derived: sum of 2 quarters · filed 2019-03-01 | $775.00K derived: sum of 3 quarters · filed 2019-03-01 | $2.24M derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | $3.60M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $3.80M derived: sum of 2 quarters · filed 2019-03-01 | $5.26M derived: sum of 3 quarters · filed 2019-03-01 | $4.82M 10-K · filed 2019-03-01 |
| 2016-09-30 | $207.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $1.67M derived: sum of 2 quarters · filed 2017-11-14 | $1.22M 10-Q · filed 2017-11-14 | $2.98M derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-06-30 | $1.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $1.01M 10-Q · filed 2017-08-10 | $2.77M derived: sum of 3 quarters · filed 2018-03-09 | $3.54M derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-03-31 | -$450.00K 10-Q · filed 2017-05-11 | $1.31M derived: sum of 2 quarters · filed 2018-03-09 | $2.08M derived: sum of 3 quarters · filed 2018-03-09 | |
| 2015-12-31 | $1.76M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $2.53M derived: sum of 2 quarters · filed 2018-03-09 | $2.63M 10-K · filed 2018-03-09 | |
| 2015-09-30 | $767.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $870.00K 10-Q · filed 2016-11-10 | ||
| 2015-06-30 | $103.00K 10-Q · filed 2016-09-01 | |||
| 2014-12-31 | $1.68M 10-K · filed 2017-03-13 |